Crandall Ryan: insider trades.
Crandall Ryan reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Crandall Ryan
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Marimed Inc. (MRMD) | Officer · Chief Commercial Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-28 | Marimed Inc. | M | 6,046 | $0 | 1,130,292 | Form 4 |
| 2026-09-28 | Marimed Inc. | F | 2,095 | $0.08 | 1,128,197 | Form 4 |
| 2026-07-15 | Marimed Inc. | M | 32,813 | $0 | 1,135,616 | Form 4 |
| 2026-07-15 | Marimed Inc. | F | 11,370 | $0.07 | 1,124,246 | Form 4 |
Questions
What stock did Crandall Ryan buy or sell?
Crandall Ryan reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Crandall Ryan the same person as other filers with this name?
This page covers SEC CIK 2062820 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/crandall-ryan-2062820.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.